Results 141 to 150 of about 120,918,193 (215)

CDC Health Advisory Regarding the Potential for Circulation of Drifted Influenza a (H3N2) Viruses [PDF]

December 03, 2014, 16:00 ET (4:00 PM ET)CDCHAN-00374CDC is reminding clinicians of the benefits of influenza antiviral medications and urging continued influenza vaccination of unvaccinated patients this influenza season.Summary: Influenza activity is ...

core  

Influenza A/H3N2 epidemiology in England during the 2025 to 2026 season: a mathematical modelling study. [PDF]

Commun Health
Hay JA, Alahakoon P, Greenshields-Watson A, Kendall M, Ghafari M, Wymant C, Hinch R, Ferretti L, Panovska-Griffiths J, Fraser C.   +9 more
europepmc   +1 more source

Hemagglutination Inhibition and Alternate Serologic Responses Following Influenza A(H3N2) Virus Infection. [PDF]

Influenza Other Respir Viruses
Chen B, Zambrana JV, Shotwell A, Sanchez N, Plazaola M, Ojeda S, Lopez R, Stadlbauer D, Kuan G, Balmaseda A, Krammer F, Gordon A.   +11 more
europepmc   +1 more source

Antiviral Resistance Associated With Multiple Mutations Occurring in Seasonal Influenza A(H3N2) Virus in a Patient Treated With Oseltamivir. [PDF]

Clin Case Rep
Hussain S, Guo C, Deng YM, Deshpande N, Chanthalavanh P, Spirason N, Burmas L, Peck H, Gardiner BJ, Barr IG.   +9 more
europepmc   +1 more source

Characterisation of a human monoclonal antibody targeting a conserved epitope at the base of the HA head of influenza A(H3N2) virus. [PDF]

EBioMedicine
Yamayoshi S, Hamabata T, Inoue Y, Kiso M, Okuda M, Akasaka H, Shihoya W, Imamura T, Matsuzawa Y, Jubishi D, Iwatsuki-Horimoto K, Wilson PC, Nureki O, Kawaoka Y.   +13 more
europepmc   +1 more source

Influenza A(H3N2) Subclade K During the 2025-26 Season and Differential Humoral Responses in Vaccinated Individuals Versus Vaccinated Convalescents in Israel. [PDF]

Vaccines (Basel)
Nemet I, Zuckerman NS, Atari N, Kliker L, Jurkowicz M, Gilboa M, Weiss-Ottolenghi Y, Keller N, Stein M, Regev-Yochay G, Lustig Y, Mandelboim M.   +11 more
europepmc   +1 more source

Early circulation of influenza A(H3N2) subclade K: antigenic drift and vaccine effectiveness. [PDF]

Osong Public Health Res Perspect
Naz M, Jogezai SFK, Ghaffar G.
europepmc   +1 more source

Influenza A (H3N2), subclado K: Influenza A (H3N2), subclade K

La influenza estacional causa anualmente entre 290,000 y 650,000 muertes por causas respiratorias. En junio de 2025, se detectó en Nueva York una nueva variante de influenza A(H3N2), denominada subclado K (J.2.4.1), producto de una deriva antigénica con ...
Cordero, Cruz, de Carvajal, Ana Carvajal, Valenzuela, Patricia   +2 more
core  

Influenza A(H3N2) Subclade K: Epidemiology, Molecular Evolution and Vaccine Effectiveness in Europe. [PDF]

Pathogens
Scarvaglieri I, De Francesco MA, Alberti M, Cesanelli F, Salvi M, Tiecco G, Castelli F, Quiros-Roldan E.   +7 more
europepmc   +1 more source

Is the emerging influenza A(H3N2) K subclade a specific threat for older adults? [PDF]

Geroscience
Quarleri J, Delpino MV.
europepmc   +1 more source